Overview

Medication-assisted Treatment for Injecting Drug Users in Vietnam

Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
0
Participant gender:
All
Summary
HIV continues to spread around the world and new infections in Asia are one of the most important areas for prevention among drug using populations. There is strong and consistent evidence from several countries that while injection drug users (IDU) continue to be a source of new infections, treatment of opiate addiction is an effective prevention measure against further spread. The project evaluated the implementation of a comprehensive opioid use disorder treatment program co-located with an HIV clinic in Ho Chi Minh City, Vietnam. The program includes medication for opioid use disorder (methadone, buprenorphine/naloxone), standardized counseling sessions (BDRC) and HIV testing and care (for people living with HIV).
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Expertise France
National Institute of Drug Abuse
Treatments:
Buprenorphine
Buprenorphine, Naloxone Drug Combination
Methadone
Naloxone
Criteria
Inclusion Criteria:

- • 18 or more years of age

- Meets DSM-5 criteria for opiate use disorder

- Positive urine drug screen for heroin or other opiates

- Interested in methadone maintenance or Suboxone® treatment for opiate use
disorder

- Injected heroin within past 30 days by self-report, documented by "tracks" or
puncture marks

- Willingness and ability to give informed consent and otherwise participate

- Provision of adequate locator information

Exclusion Criteria:

- • Clinically significant cognitive impairment, schizophrenia, paranoid disorder,
bipolar disorder

- Known neurological, cardiovascular, renal, or other medical disorder that is
likely to impair or make the patient's participation hazardous

- Physiologically dependent on alcohol, benzodiazepines, or other sedative type
drugs

- Pending legal charges with likely incarceration within next 12 months